For example, Yang H et al. found that the mean serum level of DKK-1 in patients with early hepatocellular carcinoma was significantly higher than that in patients with cirrhosis, noncirrhotic chronic hepatitis B, benign liver tumors and healthy individuals (p < 0.001). This evidence concerns the gene DKK1 and hepatocellular carcinoma.